Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MYCOPID: Mycophenolate Mofetil for IVIG Weaning in CIDP
NCT02494505Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2013
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mycophenolate mofetil in Chronic inflammatory demyelinating polyradiculopathy (CIDP), sponsored by Assistance publique - Hôpitaux de Paris. Started Nov 2013; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
Chronic inflammatory demyelinating polyradiculopathy (CIDP)
Beyond the preview
Go deeper on NCT02494505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02494505.